Results 91 to 100 of about 1,327 (120)

Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study. [PDF]

Breast
Bianco N, Valenza C, Milano M, Multinu R, Battaiotto E, Cavallone M, Malvezzi G, Trapani D, Della Vigna P, Bonomo G, Varano GM, Maiettini D, Pitoni MG, Sangalli C, Munzone E, Curigliano G, Colleoni MA, Orsi F.   +17 more
europepmc   +1 more source

Maintenance Liposomal Doxorubicin Following Induction Doxorubicin in Soft Tissue Sarcoma: A Single-Center Observational Study. [PDF]

Curr Oncol
Faco ADS, Salehi MA, Hodroj MH, Mozafari-Lorestani K, Moria FA, Noujaim J, Saleh RR.   +6 more
europepmc   +1 more source

European lung cancer congress 2026 - the thoracic radiation oncologist's view. [PDF]

Clin Transl Radiat Oncol
Zehentmayr F, Rimner A, Bernhardt D, Käsmann L, Gkika E, El-Shafie R, Pöttgen C, Stuschke M, Guberina M, Guberina N.   +9 more
europepmc   +1 more source

Does stereotactic ablative body radiotherapy (SABR) added to continued systemic therapy improve time to treatment failure compared with physician's choice of systemic therapy in oligoprogressive ER-positive, HER2-negative advanced breast cancer? Study protocol for a multicentre, randomised, open-label phase II trial in Australian tertiary cancer centres (AVATAR-II). [PDF]

BMJ Open
Connolly E, White M, Siva S, Bressel M, See A, Hunter K, Tan J, Panettieri V, Day D, Byrne K, McCartney A, Webber K, Woodford K, David S.   +13 more
europepmc   +1 more source

Immunotherapy rechallenge in gastric cancer: resistance mechanisms, molecular stratification, and precision decision-making. [PDF]

Front Immunol
Jiang YC, Zheng LL, Fu MG, Zheng BJ.
europepmc   +1 more source

Comments on "Efficacy of radiotherapy and radiotherapy with hyperthermia to delay change of systemic therapy in patients with metastatic melanoma". [PDF]

Clin Transl Radiat Oncol
Shekhar H, Aphale P, Dokania S.
europepmc   +1 more source

Thermal ablation of breast cancer liver metastases achieves durable control and prolongs chemotherapy-free survival in selected patients

Ahmed N, Okines A, McGrath S, Parton M, Kipps E, Turner N, Johnston E, Johnston S, Fotiadis N.   +8 more
europepmc   +1 more source

Comparison of Post-Resistance Treatment Outcomes in EGFR-Mutated NSCLC Patients Following Third-Generation EGFR-TKI Therapy: A Retrospective Cohort Study. [PDF]

Technol Cancer Res Treat
Li X, Ding K, Liu D, Song R, Peng Z, Xu Y, Lu Y.   +6 more
europepmc   +1 more source

Stereotactic Body Radiotherapy for Oligometastatic Disease in Melanoma Patients Receiving Immunotherapy: A Single-Center Retrospective Analysis. [PDF]

Cancers (Basel)
Lekić M, Kaučić H, Kosmina D, Prološčić I, Ursi G, Leipold V, Divošević S, Ilić MK, Schwarz K, Schwarz D, Vučinić D.   +10 more
europepmc   +1 more source